EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-Vaccination Serologic Testing

Wei-Ju Su, Huey-Ling Chen, Shu-Fong Chen, Yu-Lun Liu, Ting-Ann Wang, Yee-Chuan Ho, Mei-Hwei Chang

Clinical Infectious Diseases · 26.09.2024 · 79 (3) · 690-700

DOI: 10.1093/cid/ciae176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 02.04.2024. Verfasst von Wei-Ju Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan. Hauptthemen laut MEDLINE: Infectious Disease Transmission, Vertical, Hepatitis B, Hepatitis B Surface Antigens, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taiwan Centers for Disease Control.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evaluation of the impact of a hepatitis B virus (HBV) prevention program that incorporates maternal antiviral prophylaxis on mother-to-child transmission (MTCT) is limited using real-world data.

Methods

We analyzed data on maternal HBV screening, neonatal immunization, and post-vaccination serologic testing (PVST) for hepatitis B surface antigen (HBsAg) among at-risk infants born to HBV carrier mothers from the National Immunization Information System during 2008–2022. Through linkage with the National Health Insurance Database, information on maternal antiviral therapy was obtained. Multivariate logistic regression was performed to explore MTCT risk in relation to infant–mother characteristics and prevention strategies.

Results

In total, 2 460 218 deliveries with maternal HBV status were screened. Between 2008 and 2022, the annual HBsAg and hepatitis B e antigen (HBeAg) seropositivity rates among native pregnant women decreased from 12.2% to 2.6% and from 2.7% to 0.4%, respectively (P for both trends < .0001). Among the 22 859 at-risk infants who underwent PVST, the MTCT rates differed between infants born to HBsAg-positive/HBeAg-negative and HBeAg-positive mothers (0.75% and 6.33%, respectively; P < .001). MTCT risk increased with maternal HBeAg positivity (odds ratio [OR], 9.29; 95% confidence interval [CI], 6.79–12.73) and decreased with maternal antiviral prophylaxis (OR, 0.28; 95% CI, .16–.49). For infants with maternal HBeAg positivity, MTCT risk was associated with mothers born in the immunization era (OR, 1.40; 95% CI, 1.17–1.67).

Conclusions

MTCT was related to maternal HBeAg positivity and effectively prevented by maternal prophylaxis in the immunized population. At-risk infants born to maternal vaccinated cohorts might possibly pose further risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infectious Disease Transmission, VerticalHepatitis BHepatitis B Surface AntigensPregnancy Complications, InfectiousHepatitis B VaccinesHumansFemalePregnancyInfant, NewbornAdultInfantHepatitis B e AntigensSerologic TestsYoung AdultHepatitis B virusVaccinationMass ScreeningMale

Stichwörter der Autor:innen

HBV vaccinationHBsAg carriermother-to-child transmissionpost-vaccination serologic testingscreening pregnant women

Substanzen

Hepatitis B Surface AntigensHepatitis B VaccinesHepatitis B e Antigens

Autor:innen und Institutionen

  • Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan.
  • Department of Pediatrics, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.
  • Good Liver Clinic, Good Liver Foundation, Taipei, Taiwan.
  • Department and Graduate Institute of Medical Education and Bioethics, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
  • Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.

Förderung

  • Taiwan Centers for Disease Control

Zitieren

APA

Su, W. J., Chen, H. L., Chen, S. F., Liu, Y. L., Wang, T. A., Ho, Y. C., & Chang, M. H. (2024). Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-Vaccination Serologic Testing. Clinical Infectious Diseases, 79(3), 690-700. https://doi.org/10.1093/cid/ciae176

Vancouver

Su WJ, Chen HL, Chen SF, Liu YL, Wang TA, Ho YC, et al. Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-Vaccination Serologic Testing. Clinical Infectious Diseases. 2024;79(3):690-700. doi:10.1093/cid/ciae176

BibTeX
@article{Su2024,
  author = {Su, Wei-Ju and Chen, Huey-Ling and Chen, Shu-Fong and Liu, Yu-Lun and Wang, Ting-Ann and Ho, Yee-Chuan and Chang, Mei-Hwei},
  title = {Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-Vaccination Serologic Testing},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {79},
  number = {3},
  pages = {690--700},
  doi = {10.1093/cid/ciae176}
}
Kostenlos starten →